Efficacy and Safety of Zerafil® (Omalizumab) in Participants With Uncontrolled Moderate to Severe Allergic Asthma

Clinical trial NCT05813470 · COMPLETED

Trial details

NCT number: NCT05813470
Sponsor: Cinnagen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Allergic Asthma Uncontrolled Moderate to Severe

Start date: 2021-01-18
Primary completion: 2023-01-15
Enrollment: 256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.